Literature DB >> 17894684

Subthreshold micropulse diode laser photocoagulation for clinically significant diabetic macular oedema: a three-year follow up.

Sobha Sivaprasad1, Ranjit Sandhu, Anamika Tandon, Khalid Sayed-Ahmed, Dominic A McHugh.   

Abstract

PURPOSE: To report the long-term visual outcome of subthreshold micropulse diode laser photocoagulation for clinically significant diffuse diabetic macular oedema (CSME).
DESIGN: Non-comparative case-series.
METHODS: The main outcome measures of this 3-year follow-up study of infrared (810 nm) subthreshold diode micropulse laser photocoagulation for CSME were visual outcome and the angiographic CSME status of 19 patients (25 eyes).
RESULTS: Visual acuity stabilized or improved in 84% of treated eyes by the end of the first year. The result was maintained in the second year and by the third year, 92% maintained vision. However, more patients needed supplementary grid laser in the third year than in the second year. CSME decreased in 92% of the eyes and resolved in 88% in the first year. By the second year, 92% showed complete resolution. However, in the third year, recurrent CSME was noted in 28% of patients.
CONCLUSION: This study has the longest follow up reported so far and demonstrating that subthreshold micropulse diode laser photocoagulation has a beneficial long-term effect on visual acuity and resolution of CSME with minimal chorio-retinal damage.

Entities:  

Mesh:

Year:  2007        PMID: 17894684     DOI: 10.1111/j.1442-9071.2007.01566.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  27 in total

Review 1.  [Diabetic maculopathy and retinopathy. Functional and sociomedical significance].

Authors:  J G Garweg; A Wenzel
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

Review 2.  Retinal light toxicity.

Authors:  P N Youssef; N Sheibani; D M Albert
Journal:  Eye (Lond)       Date:  2010-10-29       Impact factor: 3.775

3.  Subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy: safety profile and treatment outcome.

Authors:  N K Yadav; C Jayadev; A Mohan; P Vijayan; R Battu; S Dabir; B Shetty; R Shetty
Journal:  Eye (Lond)       Date:  2015-01-23       Impact factor: 3.775

Review 4.  Current approaches to the management of diabetic retinopathy and diabetic macular oedema.

Authors:  Francesco Boscia
Journal:  Drugs       Date:  2010-11-12       Impact factor: 9.546

5.  Long-term SD-OCT/SLO imaging of neuroretina and retinal pigment epithelium after subthreshold infrared laser treatment of drusen.

Authors:  Francesca Mojana; Manpreet Brar; Lingyun Cheng; Dirk-Uwe G Bartsch; William R Freeman
Journal:  Retina       Date:  2011-02       Impact factor: 4.256

6.  Indocyanine green enhanced subthreshold diode-laser micropulse photocoagulation treatment of chronic central serous chorioretinopathy.

Authors:  F Ricci; F Missiroli; F Regine; M Grossi; G Dorin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-17       Impact factor: 3.117

7.  Sub-threshold micro-pulse diode laser treatment in diabetic macular edema: A Meta-analysis of randomized controlled trials.

Authors:  Gang Qiao; Hai-Ke Guo; Yan Dai; Xiao-Li Wang; Qian-Li Meng; Hui Li; Xiang-Hui Chen; Zhong-Lun Chen
Journal:  Int J Ophthalmol       Date:  2016-07-18       Impact factor: 1.779

8.  Preliminary assessment of celecoxib and microdiode pulse laser treatment of diabetic macular edema.

Authors:  Emily Y Chew; Jonghyeon Kim; Hanna R Coleman; Lloyd Paul Aiello; Gary Fish; Michael Ip; Julia A Haller; Maria Figueroa; Daniel Martin; David Callanan; Robert Avery; Keri Hammel; Darby J S Thompson; Frederick L Ferris
Journal:  Retina       Date:  2010-03       Impact factor: 4.256

9.  Application of subthreshold laser therapy in retinal diseases: a review.

Authors:  Spencer M Moore; Daniel L Chao
Journal:  Expert Rev Ophthalmol       Date:  2018-12-11

10.  Müller cell activation, proliferation and migration following laser injury.

Authors:  Mark A Tackenberg; Budd A Tucker; Jesse S Swift; Caihui Jiang; Stephen Redenti; Kenneth P Greenberg; John G Flannery; Andreas Reichenbach; Michael J Young
Journal:  Mol Vis       Date:  2009-09-17       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.